Pfizer Inc. (PFE)
27.98
-0.09
(-0.32%)
USD |
NYSE |
Aug 24, 16:00
27.96
-0.02
(-0.07%)
After-Hours: 20:00
Pfizer Shareholders Equity (Quarterly) : 85.19B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 85.19B |
| March 31, 2026 | 90.10B |
| December 31, 2025 | 86.48B |
| September 30, 2025 | 92.80B |
| June 30, 2025 | 88.70B |
| March 31, 2025 | 90.34B |
| December 31, 2024 | 88.20B |
| September 30, 2024 | 92.29B |
| June 30, 2024 | 87.70B |
| March 31, 2024 | 92.28B |
| December 31, 2023 | 89.01B |
| September 30, 2023 | 96.93B |
| June 30, 2023 | 99.02B |
| March 31, 2023 | 100.97B |
| December 31, 2022 | 95.66B |
| September 30, 2022 | 92.63B |
| June 30, 2022 | 87.21B |
| March 31, 2022 | 82.42B |
| December 31, 2021 | 77.20B |
| September 30, 2021 | 75.69B |
| June 30, 2021 | 70.04B |
| March 31, 2021 | 68.62B |
| December 31, 2020 | 63.24B |
| September 30, 2020 | 65.26B |
| June 30, 2020 | 64.34B |
| Date | Value |
|---|---|
| March 31, 2020 | 65.03B |
| December 31, 2019 | 63.14B |
| September 30, 2019 | 65.10B |
| June 30, 2019 | 59.57B |
| March 31, 2019 | 58.81B |
| December 31, 2018 | 63.41B |
| September 30, 2018 | 71.32B |
| June 30, 2018 | 69.78B |
| March 31, 2018 | 70.18B |
| December 31, 2017 | 71.31B |
| September 30, 2017 | 60.77B |
| June 30, 2017 | 58.37B |
| March 31, 2017 | 58.44B |
| December 31, 2016 | 59.54B |
| September 30, 2016 | 63.31B |
| June 30, 2016 | 62.77B |
| March 31, 2016 | 63.07B |
| December 31, 2015 | 64.72B |
| September 30, 2015 | 66.84B |
| June 30, 2015 | 66.89B |
| March 31, 2015 | 67.30B |
| December 31, 2014 | 71.30B |
| September 30, 2014 | 77.99B |
| June 30, 2014 | 76.63B |
| March 31, 2014 | 77.77B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
| Merck & Co., Inc. | 41.93B |
| Bristol Myers Squibb Co. | 22.32B |
| Viatris, Inc. | 14.26B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 201.13B |
| Total Liabilities (Quarterly) | 115.64B |
| Debt to Equity Ratio | 0.7418 |
| Current Ratio | 1.267 |
| Net Debt Paydown Yield | -0.16% |